PharmiWeb.com - Global Pharma News & Resources
01-Feb-2019

Choroidal Neovascularization - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Choroidal Neovascularization - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Choroidal Neovascularization - Pipeline Insight, 2019 report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Choroidal Neovascularization development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the Report

  • The report provides a snapshot of the pipeline development for the Choroidal Neovascularization
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Choroidal Neovascularization
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Choroidal Neovascularization
  • The report also covers the dormant and discontinued pipeline projects related to Choroidal Neovascularization

Topics Covered

1. Report Introduction

2. Choroidal Neovascularization Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Choroidal Neovascularization

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Formycon AG
  • Genentech Inc
  • Graybug Vision Inc
  • Lupin Ltd
  • Mabion SA
  • Navigen Inc
  • NovelMed Therapeutics Inc
  • Noxxon Pharma AG
  • Promedior Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vz74b4/choroidal?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190201005237/en/

Editor Details

Last Updated: 01-Feb-2019